COVID-19 is an unprecedented challenge. The CoVIg-19 Plasma Alliance is an unprecedented partnership of the world’s leading plasma companies, spanning plasma collection, development, production, and distribution. Rather than pursue our individual research, we are putting public and patient health first by working together. Our goals are to accelerate the development of a potential treatment, improve our chances of success, and increase supply of the potential treatment.
In addition to those announced at its inception—Biotest, BPL, CSL Behring, LFB, Octapharma, and Takeda—the Alliance welcomes new industry members ADMA Biologics, BioPharma Plasma, GC Pharma, and Sanquin. The Bill & Melinda Gates Foundation is providing advisory support. Microsoft is providing technology including the Alliance website and the Plasma Bot for donor recruitment.
Visit the CoVIg-19 Plasma Alliance website to learn more.